Pharmaceutical composite for preventing and curing 2-type diabetes and preparation method thereof
What is Al technical title?
Al technical title is built by PatSnap Al team. It summarizes the technical point description of the patent document.
A technology for type 2 diabetes and drugs, applied in drug combinations, pharmaceutical formulations, medical preparations containing active ingredients, etc. Urine volume, the effect of suppressing insulin resistance
Active Publication Date: 2012-02-01
DONGGUAN MATHEMATICAL ENG ACAD OF CHINESE MEDICINE GUANGZHOU UNIV OF CHINESE MEDICINE
View PDF0 Cites 0 Cited by
Summary
Abstract
Description
Claims
Application Information
AI Technical Summary
This helps you quickly interpret patents by identifying the three key elements:
Problems solved by technology
Method used
Benefits of technology
Problems solved by technology
Although the above-mentioned Chinese patent medicines have a certain curative effect on diabetes and its chronic complications, they generally have defects such as low technical content, backward dosage form, large dosage, low bioavailability, slow onset of effect, and unstable curative effect.
Method used
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more
Image
Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
Click on the blue label to locate the original text in one second.
Reading with bidirectional positioning of images and text.
Smart Image
Examples
Experimental program
Comparison scheme
Effect test
preparation example Construction
[0022] The preparation method of the pharmaceutical combination of the present invention comprises the following steps:
[0023] ①, firstly prepare total flavonoids of pueraria, get the original medicinal pieces of pueraria, add 12 times the amount of 80% ethanol and heat under reflux for 2 times, each time for 2 hours, filter the dregs, merge the filtrate, and the obtained filtrate is subjected to decompression and recovery of ethanol to obtain medicinal liquid; AB-8 macroporous resin was adsorbed on the above medicinal solution, the loading concentration was 0.1 g crude drug / ml, the loading volume was 10 BV, the flow rate was 1 ml / min, pre-adsorption for 2 hours, re-adsorption for 2 times, and then the adsorption site was washed with water until No reducing sugar reaction; the adsorption site is eluted with 50% ethanol at a volume of 10 BV, the flow rate is 2ml / min, the ethanol solution is recovered under reduced pressure, and after freeze-drying, it is pulverized into 14-mes...
example 1
[0026] Example 1 (hard capsule):
[0027] Take 50g total flavonoids of Pueraria lobata, 25g total astragalus saponins, add 100g dextrin, add starch to 250g, mix well, spray with 40% ethanol to moisten, make into granules, dry below 60 ℃, sieve, put into No. 1 capsule, make 1000 hard capsules (0.25g / capsule). Dosage: 2 capsules each time, 2 times a day.
example 2
[0028] Example 2 (tablet):
[0029]Take 50g total flavonoids of Pueraria lobata, 25g total astragalus saponins, add 100g dextrin, add starch to 200g, mix well to make granules, dry below 60°C, press into 1000 tablets (0.20g / tablet), coat with film, and get . Dosage: 2 tablets each time, 2 times a day.
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more
PUM
Login to view more
Abstract
The invention provides a pharmaceutical composition for preventing and treating type II diabetes and a preparation method thereof. The pharmaceutical composition for preventing and treating the type II diabetes is composed of pharmaceutical raw materials of 40-50 parts by weight of total flavonoids of kudzuvine root and 20-25 parts by weight of total saponins of membranous milkvetch root. The pharmaceutical composition has the effects of benefiting qi, nourishing yin, promoting fluid production and quenching thirsty, the pharmacological studies show that the pharmaceutical composition has the roles of reducing blood sugar, improving glucose tolerance, reducing urine volume, suppressing insulin resistance, lowering lipids and reducing body weight, and the pharmaceutical composition can be used for preventing and treating the type II diabetes.
Description
technical field [0001] The invention relates to a traditional Chinese medicine composition, in particular to a medicine combination for preventing and treating type 2 diabetes. Background technique [0002] Diabetes Mellitus (DM) usually refers to type 2 diabetes mellitus (T2DM), which accounts for more than 90% of the total number of DM. The third major category of diseases that seriously threaten human health after vascular diseases and tumors. Its clinical manifestations are metabolic disorder syndrome, such as "three more and one less": polyuria, polydipsia, polyphagia and weight loss. Serious complications can occur in the later stage of diabetes, which are mostly manifested as infection, diabetic nephropathy, diabetic retinopathy, cataract, neuropathy and ketoacidosis. The harm to the human body far exceeds that of diabetes itself, so diabetes is also called "The source of all diseases". With the improvement of people's living standards in our country, the change of...
Claims
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more
Application Information
Patent Timeline
Application Date:The date an application was filed.
Publication Date:The date a patent or application was officially published.
First Publication Date:The earliest publication date of a patent with the same application number.
Issue Date:Publication date of the patent grant document.
PCT Entry Date:The Entry date of PCT National Phase.
Estimated Expiry Date:The statutory expiry date of a patent right according to the Patent Law, and it is the longest term of protection that the patent right can achieve without the termination of the patent right due to other reasons(Term extension factor has been taken into account ).
Invalid Date:Actual expiry date is based on effective date or publication date of legal transaction data of invalid patent.
Login to view more
Patent Type & Authority Patents(China)
IPC IPC(8): A61K36/481A61P3/10
Inventor 高英赖小平王春怡
Owner DONGGUAN MATHEMATICAL ENG ACAD OF CHINESE MEDICINE GUANGZHOU UNIV OF CHINESE MEDICINE
Login to view more 
Login to view more